PCV13	B:C3152625
serotype	O
decrease	O
in	O
Italian	O
adolescents	O
and	O
adults	O
in	O
the	O
post	O
-	O
PCV13	O
era	O
:	O

PCV13	O
serotype	B:C0449943
decrease	O
in	O
Italian	O
adolescents	O
and	O
adults	O
in	O
the	O
post	O
-	O
PCV13	O
era	O
:	O

PCV13	O
serotype	O
decrease	O
in	O
Italian	B:C0337810
adolescents	O
and	O
adults	O
in	O
the	O
post	O
-	O
PCV13	O
era	O
:	O

PCV13	O
serotype	O
decrease	O
in	O
Italian	O
adolescents	O
and	O
adults	O
in	O
the	O
post	O
-	O
PCV13	B:C3152625
era	O
:	O

Herd	B:C1135927
protection	I:C1135927
from	O
children	O
or	O
secular	O
trend	O
?	O

In	O
2010	O
PCV13	B:C3152625
replaced	O
PCV7	O
in	O
the	O
pediatric	O
vaccination	O
schedule	O
for	O
Italian	O
children	O
.	O

In	O
2010	O
PCV13	O
replaced	O
PCV7	B:C3852780
in	O
the	O
pediatric	O
vaccination	O
schedule	O
for	O
Italian	O
children	O
.	O

In	O
2010	O
PCV13	O
replaced	O
PCV7	O
in	O
the	O
pediatric	O
vaccination	B:C0042196
schedule	O
for	O
Italian	O
children	O
.	O

In	O
2010	O
PCV13	O
replaced	O
PCV7	O
in	O
the	O
pediatric	O
vaccination	O
schedule	O
for	O
Italian	B:C0337810
children	O
.	O

While	O
a	O
strong	O
herd	B:C1135927
effect	I:C1135927
was	O
demonstrated	O
for	O
PCV7	O
,	O
a	O
possible	O
herd	O
effect	I:C1135927
due	O
to	O
PCV13	O
is	O
still	O
under	O
debate	O
.	O

While	O
a	O
strong	O
herd	O
effect	I:C1135927
was	O
demonstrated	O
for	O
PCV7	B:C3852780
,	O
a	O
possible	O
herd	O
effect	I:C1135927
due	O
to	O
PCV13	O
is	O
still	O
under	O
debate	O
.	O

While	O
a	O
strong	O
herd	O
effect	I:C1135927
was	O
demonstrated	O
for	O
PCV7	O
,	O
a	O
possible	O
herd	B:C1135927
effect	I:C1135927
due	O
to	O
PCV13	O
is	O
still	O
under	O
debate	O
.	O

While	O
a	O
strong	O
herd	O
effect	I:C1135927
was	O
demonstrated	O
for	O
PCV7	O
,	O
a	O
possible	O
herd	O
effect	I:C1135927
due	O
to	O
PCV13	B:C3152625
is	O
still	O
under	O
debate	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	B:C0038410
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	O
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	B:C0449943
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	O
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	B:C3152625
eras	O
in	O
unvaccinated	O
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	B:C0243095
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	O
Italian	B:C0337810
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	O
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	B:C0022885
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	O
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	B:C0032269
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	O
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	B:C0022277
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	O
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	B:C3152625
vaccination	O
of	O
children	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
differences	O
in	O
the	O
distribution	O
of	O
pneumococcal	O
serotypes	O
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
in	O
unvaccinated	O
Italian	O
adolescents	O
and	O
adults	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
from	O
3	O
Italian	O
Regions	I:C0022277
with	O
a	O
high	O
rate	O
of	O
PCV13	O
vaccination	B:C0042196
of	O
children	O
.	O

Adolescents	O
and	O
adults	O
admitted	O
with	O
laboratory	B:C0022885
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
in	O
the	O
hospitals	O
of	O
3	O
Italian	O
Regions	I:C0022277
(	O
Friuli	O
-	I:C0017446
Venezia	I:C0017446
Giulia	I:C0017446
,	O
Emilia	O
Romagna	I:C0017446
,	O
and	O
Tuscany	O
)	O
between	O
April	O
2006	O
and	O
June	O
2016	O
were	O
included	O
in	O
the	O
study	O
.	O

Adolescents	O
and	O
adults	O
admitted	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	B:C0032269
infection	I:C0032269
in	O
the	O
hospitals	O
of	O
3	O
Italian	O
Regions	I:C0022277
(	O
Friuli	O
-	I:C0017446
Venezia	I:C0017446
Giulia	I:C0017446
,	O
Emilia	O
Romagna	I:C0017446
,	O
and	O
Tuscany	O
)	O
between	O
April	O
2006	O
and	O
June	O
2016	O
were	O
included	O
in	O
the	O
study	O
.	O

Adolescents	O
and	O
adults	O
admitted	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
in	O
the	O
hospitals	B:C0019994
of	O
3	O
Italian	O
Regions	I:C0022277
(	O
Friuli	O
-	I:C0017446
Venezia	I:C0017446
Giulia	I:C0017446
,	O
Emilia	O
Romagna	I:C0017446
,	O
and	O
Tuscany	O
)	O
between	O
April	O
2006	O
and	O
June	O
2016	O
were	O
included	O
in	O
the	O
study	O
.	O

Adolescents	O
and	O
adults	O
admitted	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
in	O
the	O
hospitals	O
of	O
3	O
Italian	B:C0022277
Regions	I:C0022277
(	O
Friuli	O
-	I:C0017446
Venezia	I:C0017446
Giulia	I:C0017446
,	O
Emilia	O
Romagna	I:C0017446
,	O
and	O
Tuscany	O
)	O
between	O
April	O
2006	O
and	O
June	O
2016	O
were	O
included	O
in	O
the	O
study	O
.	O

Adolescents	O
and	O
adults	O
admitted	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
in	O
the	O
hospitals	O
of	O
3	O
Italian	O
Regions	I:C0022277
(	O
Friuli	B:C0017446
-	I:C0017446
Venezia	I:C0017446
Giulia	I:C0017446
,	O
Emilia	O
Romagna	I:C0017446
,	O
and	O
Tuscany	O
)	O
between	O
April	O
2006	O
and	O
June	O
2016	O
were	O
included	O
in	O
the	O
study	O
.	O

Adolescents	O
and	O
adults	O
admitted	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
in	O
the	O
hospitals	O
of	O
3	O
Italian	O
Regions	I:C0022277
(	O
Friuli	O
-	I:C0017446
Venezia	I:C0017446
Giulia	I:C0017446
,	O
Emilia	B:C0017446
Romagna	I:C0017446
,	O
and	O
Tuscany	O
)	O
between	O
April	O
2006	O
and	O
June	O
2016	O
were	O
included	O
in	O
the	O
study	O
.	O

Adolescents	O
and	O
adults	O
admitted	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
in	O
the	O
hospitals	O
of	O
3	O
Italian	O
Regions	I:C0022277
(	O
Friuli	O
-	I:C0017446
Venezia	I:C0017446
Giulia	I:C0017446
,	O
Emilia	O
Romagna	I:C0017446
,	O
and	O
Tuscany	B:C0017446
)	O
between	O
April	O
2006	O
and	O
June	O
2016	O
were	O
included	O
in	O
the	O
study	O
.	O

Diagnosis	B:C0011900
of	O
pneumococcal	O
infection	I:C0032269
and	O
serotyping	O
were	O
performed	O
with	O
Real	O
Time	I:C1709846
PCR	I:C1709846
directly	O
on	O
normally	O
sterile	O
fluids	I:C1272855
or	I:C1272855
on	I:C1272855
culture	I:C1272855
isolates	I:C1272855
.	O

Diagnosis	O
of	O
pneumococcal	B:C0032269
infection	I:C0032269
and	O
serotyping	O
were	O
performed	O
with	O
Real	O
Time	I:C1709846
PCR	I:C1709846
directly	O
on	O
normally	O
sterile	O
fluids	I:C1272855
or	I:C1272855
on	I:C1272855
culture	I:C1272855
isolates	I:C1272855
.	O

Diagnosis	O
of	O
pneumococcal	O
infection	I:C0032269
and	O
serotyping	B:C0449943
were	O
performed	O
with	O
Real	O
Time	I:C1709846
PCR	I:C1709846
directly	O
on	O
normally	O
sterile	O
fluids	I:C1272855
or	I:C1272855
on	I:C1272855
culture	I:C1272855
isolates	I:C1272855
.	O

Diagnosis	O
of	O
pneumococcal	O
infection	I:C0032269
and	O
serotyping	O
were	O
performed	O
with	O
Real	B:C1709846
Time	I:C1709846
PCR	I:C1709846
directly	O
on	O
normally	O
sterile	O
fluids	I:C1272855
or	I:C1272855
on	I:C1272855
culture	I:C1272855
isolates	I:C1272855
.	O

Diagnosis	O
of	O
pneumococcal	O
infection	I:C0032269
and	O
serotyping	O
were	O
performed	O
with	O
Real	O
Time	I:C1709846
PCR	I:C1709846
directly	O
on	O
normally	O
sterile	B:C1272855
fluids	I:C1272855
or	I:C1272855
on	I:C1272855
culture	I:C1272855
isolates	I:C1272855
.	O

523	O
patients	O
with	O
laboratory	B:C0022885
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
were	O
enrolled	O
(	O
Male	O
/	O
Female	O
ratio	O
was	O
300/223	O
,	O
1.3	O
;	O
median	O
age	O
67.1	O
,	O
IQR	O
53.4-74.9	O
)	O
.	O

523	O
patients	O
with	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	B:C0032269
infection	I:C0032269
were	O
enrolled	O
(	O
Male	O
/	O
Female	O
ratio	O
was	O
300/223	O
,	O
1.3	O
;	O
median	O
age	O
67.1	O
,	O
IQR	O
53.4-74.9	O
)	O
.	O

None	O
of	O
the	O
patients	O
had	O
been	O
vaccinated	B:C1519885
with	O
any	O
pneumococcal	O
vaccine	I:C0358314
;	O
96.4	O
%	O
were	O
serotyped	O
.	O

None	O
of	O
the	O
patients	O
had	O
been	O
vaccinated	O
with	O
any	O
pneumococcal	B:C0358314
vaccine	I:C0358314
;	O
96.4	O
%	O
were	O
serotyped	O
.	O

None	O
of	O
the	O
patients	O
had	O
been	O
vaccinated	O
with	O
any	O
pneumococcal	O
vaccine	I:C0358314
;	O
96.4	O
%	O
were	O
serotyped	B:C0449943
.	O

Overall	O
,	O
the	O
most	O
frequent	O
serotypes	B:C0449943
were	O
3	O
(	O
67/504	O
,	O
13.3	O
%	O
)	O
,	O
8	O
(	O
43/504	O
,	O
8.5	O
%	O
)	O
,	O
and	O
19A	O
(	O
38/504	O
,	O
7.5	O
%	O
)	O
.	O

Overall	O
,	O
the	O
most	O
frequent	O
serotypes	O
were	O
3	B:C0522401
(	O
67/504	O
,	O
13.3	O
%	O
)	O
,	O
8	O
(	O
43/504	O
,	O
8.5	O
%	O
)	O
,	O
and	O
19A	O
(	O
38/504	O
,	O
7.5	O
%	O
)	O
.	O

Overall	O
,	O
the	O
most	O
frequent	O
serotypes	O
were	O
3	O
(	O
67/504	O
,	O
13.3	O
%	O
)	O
,	O
8	B:C1628956
(	O
43/504	O
,	O
8.5	O
%	O
)	O
,	O
and	O
19A	O
(	O
38/504	O
,	O
7.5	O
%	O
)	O
.	O

Overall	O
,	O
the	O
most	O
frequent	O
serotypes	O
were	O
3	O
(	O
67/504	O
,	O
13.3	O
%	O
)	O
,	O
8	O
(	O
43/504	O
,	O
8.5	O
%	O
)	O
,	O
and	O
19A	B:C1532745
(	O
38/504	O
,	O
7.5	O
%	O
)	O
.	O

Serotype	B:C0449943
distribution	O
differed	O
among	O
age	O
classes	O
and	O
clinical	O
presentations	O
.	O

Overall	O
,	O
PCV13	B:C3152625
serotypes	O
accounted	O
for	O
47.6	O
%	O
of	O
cases	O
:	O
62.3	O
%	O
in	O
the	O
pre-	O
PCV13	O
era	O
and	O
45.0	O
%	O
in	O
the	O
post	O
-	O
PCV13	O
era	O
;	O
(	O
p=0.005	O
OR=2.03	O
;	O
CL	O
95	O
%	O
:	O
1.2-3.3	O
)	O
.	O

Overall	O
,	O
PCV13	O
serotypes	B:C0449943
accounted	O
for	O
47.6	O
%	O
of	O
cases	O
:	O
62.3	O
%	O
in	O
the	O
pre-	O
PCV13	O
era	O
and	O
45.0	O
%	O
in	O
the	O
post	O
-	O
PCV13	O
era	O
;	O
(	O
p=0.005	O
OR=2.03	O
;	O
CL	O
95	O
%	O
:	O
1.2-3.3	O
)	O
.	O

Overall	O
,	O
PCV13	O
serotypes	O
accounted	O
for	O
47.6	O
%	O
of	O
cases	O
:	O
62.3	O
%	O
in	O
the	O
pre-	O
PCV13	B:C3152625
era	O
and	O
45.0	O
%	O
in	O
the	O
post	O
-	O
PCV13	O
era	O
;	O
(	O
p=0.005	O
OR=2.03	O
;	O
CL	O
95	O
%	O
:	O
1.2-3.3	O
)	O
.	O

Overall	O
,	O
PCV13	O
serotypes	O
accounted	O
for	O
47.6	O
%	O
of	O
cases	O
:	O
62.3	O
%	O
in	O
the	O
pre-	O
PCV13	O
era	O
and	O
45.0	O
%	O
in	O
the	O
post	O
-	O
PCV13	B:C3152625
era	O
;	O
(	O
p=0.005	O
OR=2.03	O
;	O
CL	O
95	O
%	O
:	O
1.2-3.3	O
)	O
.	O

Serotype	B:C0522403
7	I:C0522403
F	I:C0522403
accounted	O
for	O
12/77	O
(	O
15.6	O
%	O
)	O
of	O
all	O
serotypes	O
in	O
the	O
pre-	O
PCV13	O
period	O
and	O
for	O
12/427	O
(	O
2.8	O
%	O
)	O
in	O
the	O
post	O
-	O
PCV13	O
period	O
and	O
was	O
the	O
only	O
serotype	O
significantly	O
contributing	O
to	O
the	O
difference	O
in	O
percentage	O
between	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
.	O

Serotype	O
7	I:C0522403
F	I:C0522403
accounted	O
for	O
12/77	O
(	O
15.6	O
%	O
)	O
of	O
all	O
serotypes	B:C0449943
in	O
the	O
pre-	O
PCV13	O
period	O
and	O
for	O
12/427	O
(	O
2.8	O
%	O
)	O
in	O
the	O
post	O
-	O
PCV13	O
period	O
and	O
was	O
the	O
only	O
serotype	O
significantly	O
contributing	O
to	O
the	O
difference	O
in	O
percentage	O
between	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
.	O

Serotype	O
7	I:C0522403
F	I:C0522403
accounted	O
for	O
12/77	O
(	O
15.6	O
%	O
)	O
of	O
all	O
serotypes	O
in	O
the	O
pre-	O
PCV13	B:C3152625
period	O
and	O
for	O
12/427	O
(	O
2.8	O
%	O
)	O
in	O
the	O
post	O
-	O
PCV13	O
period	O
and	O
was	O
the	O
only	O
serotype	O
significantly	O
contributing	O
to	O
the	O
difference	O
in	O
percentage	O
between	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
.	O

Serotype	O
7	I:C0522403
F	I:C0522403
accounted	O
for	O
12/77	O
(	O
15.6	O
%	O
)	O
of	O
all	O
serotypes	O
in	O
the	O
pre-	O
PCV13	O
period	O
and	O
for	O
12/427	O
(	O
2.8	O
%	O
)	O
in	O
the	O
post	O
-	O
PCV13	B:C3152625
period	O
and	O
was	O
the	O
only	O
serotype	O
significantly	O
contributing	O
to	O
the	O
difference	O
in	O
percentage	O
between	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
.	O

Serotype	O
7	I:C0522403
F	I:C0522403
accounted	O
for	O
12/77	O
(	O
15.6	O
%	O
)	O
of	O
all	O
serotypes	O
in	O
the	O
pre-	O
PCV13	O
period	O
and	O
for	O
12/427	O
(	O
2.8	O
%	O
)	O
in	O
the	O
post	O
-	O
PCV13	O
period	O
and	O
was	O
the	O
only	O
serotype	B:C0449943
significantly	O
contributing	O
to	O
the	O
difference	O
in	O
percentage	O
between	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
.	O

Serotype	O
7	I:C0522403
F	I:C0522403
accounted	O
for	O
12/77	O
(	O
15.6	O
%	O
)	O
of	O
all	O
serotypes	O
in	O
the	O
pre-	O
PCV13	O
period	O
and	O
for	O
12/427	O
(	O
2.8	O
%	O
)	O
in	O
the	O
post	O
-	O
PCV13	O
period	O
and	O
was	O
the	O
only	O
serotype	O
significantly	O
contributing	O
to	O
the	O
difference	O
in	O
percentage	O
between	O
pre	O
and	O
post	O
-	O
PCV13	B:C3152625
eras	O
.	O

Our	O
study	O
demonstrated	O
a	O
difference	O
in	O
percentage	O
in	O
serotype	B:C0449943
distribution	O
in	O
adolescents	O
and	O
adults	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
.	O

Our	O
study	O
demonstrated	O
a	O
difference	O
in	O
percentage	O
in	O
serotype	O
distribution	O
in	O
adolescents	O
and	O
adults	O
laboratory	B:C0022885
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
.	O

Our	O
study	O
demonstrated	O
a	O
difference	O
in	O
percentage	O
in	O
serotype	O
distribution	O
in	O
adolescents	O
and	O
adults	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	B:C0032269
infection	I:C0032269
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	O
eras	O
.	O

Our	O
study	O
demonstrated	O
a	O
difference	O
in	O
percentage	O
in	O
serotype	O
distribution	O
in	O
adolescents	O
and	O
adults	O
laboratory	O
-	I:C0022885
confirmed	I:C0022885
pneumococcal	O
infection	I:C0032269
between	O
the	O
pre	O
and	O
post	O
-	O
PCV13	B:C3152625
eras	O
.	O

This	O
difference	O
is	O
mainly	O
due	O
to	O
the	O
decrease	O
of	O
serotype	B:C0522403
7	I:C0522403
F	I:C0522403
.	O

Thus	O
,	O
in	O
order	O
to	O
decrease	O
disease	O
burden	O
,	O
adults	O
and	O
in	O
particular	O
the	O
elderly	O
should	O
be	O
offered	O
a	O
specific	O
vaccination	B:C0042196
program	O
.	O

